OPTN - オプティノ―ズ (OptiNose Inc.) オプティノ―ズ

 OPTNのチャート


 OPTNの企業情報

symbol OPTN
会社名 OptiNose Inc (オプティノ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 オプティノーズ(OptiNose Inc.)は製薬会社である。同社は、耳、鼻、咽喉、またはENT、及びアレルギーの専門家によって治療された患者のための製品の開発・商品化に従事する。同社の製品候補には、XHANCE(鼻ポリープ)、チャンス(慢性副鼻腔炎)OPN-300、OPN-021などがある。主力製品であるXHANCE(プロピオン酸フルチカゾン)の鼻スプレーは、鼻ポリープを伴う慢性鼻副鼻腔炎の治療用局所的に作用し強力な抗炎症性コルチコステロイドを送達するために、呼吸動力呼気供給システム(EDS)を利用する。XHANCEは、炎症の原発部位に薬物を送達することができるため、この疾患の治療基準の一部となる可能性を有する差別化された臨床プロファイルを有する。   オプティノ―ズは米国の専門医薬品企業。主に耳鼻咽喉科の疾患に対する治療薬の開発・商業化に従事する。同社製品には鼻ポリ―プの有無に関わらず慢性鼻副鼻腔炎の治療用に、局所作用の抗炎症性コルチコステロイドを送達する呼気供給システムの「XHANCE」を含む。また、偏頭痛の治療薬「AVP-825」を販売する。本社所在地はペンシルベニア州ヤ―ドレ―。   
本社所在地 1020 Stony Hill Road Suite 300 Yardley PA 19067 USA
代表者氏名 Joseph C. Scodari ジョセフ・C.スコダリ
代表者役職名 Independent Chairman of the Board
電話番号 +1 267-364-3500
設立年月日 40299
市場名 NASDAQ National Market System
ipoyear 2017年
従業員数 82人
url www.optinose.com
nasdaq_url https://www.nasdaq.com/symbol/optn
adr_tso
EBITDA EBITDA(百万ドル) -84.65000
終値(lastsale) 10.66
時価総額(marketcap) 439411958.44
時価総額 時価総額(百万ドル) 469.50300
売上高 売上高(百万ドル) 2.13900
企業価値(EV) 企業価値(EV)(百万ドル) 296.65100
当期純利益 当期純利益(百万ドル) -92.61300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 OptiNose Inc revenues increased from $0K to $2.1M. Net loss applicable to common stockholders increased from $24.5M to $55.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling general and administrative increase from $6.1M to $46.2M (expense) Interest expense increase from $862K to $4.5M (expense).

 OPTNのテクニカル分析


 OPTNのニュース

   OptiNose (NASDAQ:OPTN) Issues Quarterly Earnings Results  2021/03/04 21:50:36 Transcript Daily
OptiNose (NASDAQ:OPTN) issued its quarterly earnings results on Tuesday. The company reported ($0.46) EPS for the quarter, hitting analysts’ consensus estimates of ($0.46), MarketWatch Earnings reports. OptiNose had a negative net margin of 230.14% and a negative return on equity of 294.64%. OPTN stock traded down $0.31 during midday trading on Thursday, reaching $3.50. 55,066 […]
   OPTN Stock Price Increases Over 10% Pre-Market: Why It Happened | News Break  2021/03/03 13:20:16 News Break
The stock price of OptiNose Inc (NASDAQ: OPTN) is trading at over 10% pre-market. This is why it happened. The stock price of OptiNose Inc (NASDAQ: OPTN) – a pharmaceutical company focused on patients treated by ear, nose, and throat (ENT) and allergy specialists – is trading at over 10% pre-market. Investors appear to be responding to the company announcing its fourth quarter and full-year 2020 financial results.
   Recap: OptiNose Q4 Earnings  2021/03/03 07:18:00 Benzinga
Shares of OptiNose (NASDAQ:OPTN) decreased 0.8% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share …
   OptiNose Must-See Earnings Estimates Stock market Insights & financial analysis  2021/03/03 03:15:00 Stock Market Daily
OptiNose announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Earnings Preview for OptiNose  2021/03/02 10:06:00 Benzinga
OptiNose (NASDAQ:OPTN) unveils its next round of earnings this Wednesday, March 03. Here is Benzinga's everything-that-matters guide for the earnings …
   Nasal Polyps Treatment Market May See a Big Move : Major Giants OptiNose, Merck, Taro Pharmaceutical  2021/01/27 17:07:53 OpenPR
Stay up-to-date and exploit latest trends of Nasal Polyps Treatment Market with latest edition released by AMA. Nasal Polyps Treatment Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Nasal Polyps Treatment
   OptiNose Inc (NASDAQ:OPTN) Expected to Post Earnings of -$0.56 Per Share  2020/10/24 14:06:56 Zolmax News
Equities analysts expect OptiNose Inc (NASDAQ:OPTN) to post ($0.56) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for OptiNose’s earnings, with estimates ranging from ($0.63) to ($0.48). OptiNose posted earnings per share of ($0.69) during the same quarter last year, which suggests a positive year-over-year growth rate […]
   Brokerages Expect OptiNose Inc (NASDAQ:OPTN) Will Post Quarterly Sales of $14.69 Million  2020/10/23 02:48:41 US Banking News
Brokerages forecast that OptiNose Inc (NASDAQ:OPTN) will post sales of $14.69 million for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for OptiNose’s earnings, with the lowest sales estimate coming in at $13.60 million and the highest estimate coming in at $15.78 million. OptiNose reported sales of $12.40 million during the […]
   OptiNose Inc (NASDAQ:OPTN) Expected to Post Quarterly Sales of $14.69 Million  2020/10/23 02:48:41 US Banking News
Brokerages predict that OptiNose Inc (NASDAQ:OPTN) will report $14.69 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for OptiNose’s earnings, with estimates ranging from $13.60 million to $15.78 million. OptiNose posted sales of $12.40 million in the same quarter last year, which suggests a positive year over […]
   Zacks: Brokerages Expect OptiNose Inc (NASDAQ:OPTN) Will Announce Earnings of -$0.56 Per Share  2020/10/21 13:41:00 Transcript Daily
Analysts forecast that OptiNose Inc (NASDAQ:OPTN) will announce earnings per share of ($0.56) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for OptiNose’s earnings, with the lowest EPS estimate coming in at ($0.63) and the highest estimate coming in at ($0.48). OptiNose posted earnings per share of ($0.69) […]
   Nasal Polyps Treatment Market May See a Big Move : Major Giants OptiNose, Merck, Taro Pharmaceutical  2021/01/27 17:07:53 OpenPR
Stay up-to-date and exploit latest trends of Nasal Polyps Treatment Market with latest edition released by AMA. Nasal Polyps Treatment Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Nasal Polyps Treatment
   OptiNose Inc (NASDAQ:OPTN) Expected to Post Earnings of -$0.56 Per Share  2020/10/24 14:06:56 Zolmax News
Equities analysts expect OptiNose Inc (NASDAQ:OPTN) to post ($0.56) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for OptiNose’s earnings, with estimates ranging from ($0.63) to ($0.48). OptiNose posted earnings per share of ($0.69) during the same quarter last year, which suggests a positive year-over-year growth rate […]
   Brokerages Expect OptiNose Inc (NASDAQ:OPTN) Will Post Quarterly Sales of $14.69 Million  2020/10/23 02:48:41 US Banking News
Brokerages forecast that OptiNose Inc (NASDAQ:OPTN) will post sales of $14.69 million for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for OptiNose’s earnings, with the lowest sales estimate coming in at $13.60 million and the highest estimate coming in at $15.78 million. OptiNose reported sales of $12.40 million during the […]
   OptiNose Inc (NASDAQ:OPTN) Expected to Post Quarterly Sales of $14.69 Million  2020/10/23 02:48:41 US Banking News
Brokerages predict that OptiNose Inc (NASDAQ:OPTN) will report $14.69 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for OptiNose’s earnings, with estimates ranging from $13.60 million to $15.78 million. OptiNose posted sales of $12.40 million in the same quarter last year, which suggests a positive year over […]
   Zacks: Brokerages Expect OptiNose Inc (NASDAQ:OPTN) Will Announce Earnings of -$0.56 Per Share  2020/10/21 13:41:00 Transcript Daily
Analysts forecast that OptiNose Inc (NASDAQ:OPTN) will announce earnings per share of ($0.56) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for OptiNose’s earnings, with the lowest EPS estimate coming in at ($0.63) and the highest estimate coming in at ($0.48). OptiNose posted earnings per share of ($0.69) […]

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 オプティノ―ズ OPTN OptiNose Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)